PTX Pernix Therapeutics Holdings Inc.

0.32
-0.07  -18%
Previous Close 0.39
Open 0.41
Price To Book -0.02
Market Cap 4641871
Shares 14,505,848
Volume 5,719,418
Short Ratio
Av. Daily Volume 1,603,763

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved May 15, 2015.
TREXIMET
Adolescent migraine patients

SEC Filings

  1. 8-K - Current report 19614178
  2. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19594325
  3. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19519125
  4. CT ORDER - Confidential treatment order 181220889
  5. 8-K - Current report 181198337
  6. 10-Q - Quarterly report [Sections 13 or 15(d)] 181174408
  7. 8-K - Current report 181174391
  8. 8-K - Current report 181151634
  9. 8-K - Current report 181132809
  10. 8-K/A [Amend] - Current report 181114044